ES2065687T3 - Compuestos de inclusion, de nimesulida con ciclodextrinas. - Google Patents

Compuestos de inclusion, de nimesulida con ciclodextrinas.

Info

Publication number
ES2065687T3
ES2065687T3 ES91909437T ES91909437T ES2065687T3 ES 2065687 T3 ES2065687 T3 ES 2065687T3 ES 91909437 T ES91909437 T ES 91909437T ES 91909437 T ES91909437 T ES 91909437T ES 2065687 T3 ES2065687 T3 ES 2065687T3
Authority
ES
Spain
Prior art keywords
nimesulide
cyclodextrins
inclusion compounds
compounds
absorbed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909437T
Other languages
English (en)
Inventor
Giuseppe Bietti
Enrica Dubini
Grazia Maffione
Aldo Vidi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Italia SpA
Original Assignee
Boehringer Ingelheim Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia SpA filed Critical Boehringer Ingelheim Italia SpA
Application granted granted Critical
Publication of ES2065687T3 publication Critical patent/ES2065687T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Ceramic Products (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Ink Jet (AREA)
  • Fats And Perfumes (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE INCLUSION DE NIMESULURO CON CICLODEXTRINAS, CON UNA RELACION MOLAR DEL NIMESULURO CON RESPECTO A LA CITODEXTRINA COMPRENDIDA ENTRE 1:0.5 Y 1:15, DICHOS COMPUESTOS POSEEN UNA ALTA SOLUBILIDAD Y SE ABSORBEN MAS RAPIDAMENTE Y/O SE TOLERAN MEJOR QUE EL NIMESULURO MISMO.
ES91909437T 1990-05-22 1991-05-20 Compuestos de inclusion, de nimesulida con ciclodextrinas. Expired - Lifetime ES2065687T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02039390A IT1248475B (it) 1990-05-22 1990-05-22 Composti di inclusione di nimesulide con ciclodestrine

Publications (1)

Publication Number Publication Date
ES2065687T3 true ES2065687T3 (es) 1995-02-16

Family

ID=11166307

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909437T Expired - Lifetime ES2065687T3 (es) 1990-05-22 1991-05-20 Compuestos de inclusion, de nimesulida con ciclodextrinas.

Country Status (15)

Country Link
EP (1) EP0534995B1 (es)
JP (1) JP3417942B2 (es)
KR (1) KR100198046B1 (es)
AT (1) ATE116135T1 (es)
AU (1) AU655183B2 (es)
DE (1) DE69106361T2 (es)
DK (1) DK0534995T3 (es)
ES (1) ES2065687T3 (es)
FI (1) FI102462B1 (es)
GR (1) GR3015468T3 (es)
HK (1) HK1006413A1 (es)
HU (1) HU214336B (es)
IT (1) IT1248475B (es)
NO (1) NO304730B1 (es)
WO (1) WO1991017774A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255462B (it) * 1992-07-28 1995-11-02 Grazia Maffione Metodo di preparazione di composti di inclusione di nimesulide con ciclodestrine
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
DE69522696T2 (de) * 1994-10-05 2002-04-18 Helsinn Healthcare Sa Nimesulid zur aüsserlichen anwendung
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
RU2157683C2 (ru) 1995-10-05 2000-10-20 Хелсинн Хелткэр Са Противовоспалительный препарат для наружного применения
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
IN186315B (es) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
WO1999041233A1 (en) * 1998-02-17 1999-08-19 Micio Pharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
KR100395247B1 (ko) * 2000-08-30 2003-08-21 디디에스텍주식회사 비자극성 캡사이신 경피 투여 제형
EP1902705A1 (en) * 2006-09-22 2008-03-26 Pharmatex Italia Srl Injectable pharmaceutical nimesulide solutions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206496A1 (es) * 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas

Also Published As

Publication number Publication date
IT9020393A0 (es) 1990-05-22
IT9020393A1 (it) 1991-11-22
FI925224A (fi) 1992-11-18
DK0534995T3 (da) 1995-05-01
EP0534995A1 (en) 1993-04-07
NO924492D0 (no) 1992-11-20
ATE116135T1 (de) 1995-01-15
KR937000160A (ko) 1993-03-13
DE69106361D1 (de) 1995-02-09
JPH06502842A (ja) 1994-03-31
HU214336B (hu) 1998-03-02
EP0534995B1 (en) 1994-12-28
HK1006413A1 (en) 1999-02-26
FI102462B (fi) 1998-12-15
FI102462B1 (fi) 1998-12-15
HU9203649D0 (en) 1993-03-29
NO924492L (no) 1993-01-20
WO1991017774A1 (en) 1991-11-28
DE69106361T2 (de) 1995-05-18
AU7866591A (en) 1991-12-10
HUT65418A (en) 1994-06-28
NO304730B1 (no) 1999-02-08
AU655183B2 (en) 1994-12-08
JP3417942B2 (ja) 2003-06-16
IT1248475B (it) 1995-01-19
FI925224A0 (fi) 1992-11-18
GR3015468T3 (en) 1995-06-30
KR100198046B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
ES2065687T3 (es) Compuestos de inclusion, de nimesulida con ciclodextrinas.
FI952680A0 (fi) Injektoitavia taksaanijohdannaisiin pohjautuvia koostumuksia
YU47204B (sh) Derivati didehidro-vitamina d3
ES2110003T3 (es) Nuevas composiciones a base de derivados de la clase de los taxanos.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2141183T3 (es) Utilizacion de disolventes de hidrocarburos halogenados.
SE7714474L (sv) Alkoholiskt desinfektionsmedel med sporicid verkan
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
FI891283A0 (fi) Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning.
ES2091260T3 (es) Procedimiento para la preparacion de piridin-2,3-dicarboxilato dialquilico y derivados del mismo a partir de diclorosuccinato dialquilico.
ES2108618B1 (es) Compuestos de trifendioxazina.
SE7512231L (sv) Steriliseringsmedel
IT8920929A0 (it) Nuovi derivati del r( ) 3 chinuclidinolo.
ATE172115T1 (de) Parenterale lösungen enthaltend 3- dialkylaminoethoxybenzoylbenzofurane
ES2077891T3 (es) Empleo de oximeter derivados para la biorregulacion de las plantas.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
FI930092A0 (fi) Indanopyrrolidinkarbamater
ITMI920084A1 (it) Alchil derivati del trazodone
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
DE69014472D1 (de) Einschlussverbindungen von Dicumylperoxid mit Beta-Cyclodextrinen.
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
DE58907569D1 (de) Isomere Trimethylbicyclo[4.3.0]nonan-Derivate.
ES2008659A4 (es) Montura de gafas
ES2141379T3 (es) Mezclas de tensioactivos anhidras.
SU1464319A1 (ru) Коронароактивное антиишемическое средство

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 534995

Country of ref document: ES